Shengkui Tan

机构：Guilin Medical University, Affiliated Hospital of Youjiang Medical University for Nationalities · ORCID：0000-0002-1955-0868

发表论文 93 篇 · 总被引 931 次 · h-index 16

代表论文

• Roles and Mechanisms of Ferroptosis in Sorafenib Resistance for Hepatocellular Carcinoma (2024 · Journal of Hepatocellular Carcinoma · 被引 13)
• MAZ-mediated N6-methyladenosine modification of ZEB1 promotes hepatocellular carcinoma progression by regulating METTL3 (2025 · Journal of Translational Medicine · 被引 10)
• REXO2 up-regulation is positively correlated with poor prognosis and tumor immune infiltration in hepatocellular carcinoma (2024 · International Immunopharmacology · 被引 7)
• New advances in oral microbiology and tumor research (2025 · World Journal of Clinical Oncology · 被引 5)
• The Distribution and Associated Factors of HIV/AIDS Among Youths in Guangxi, China, From 2014 to 2021: Bayesian Spatiotemporal Analysis (2024 · JMIR Public Health and Surveillance · 被引 4)
• LL22NC03-N14H11.1 regulates the m6A modification of MYC and promotes glycolytic activity in hepatocellular carcinoma cells by inhibiting IGF2BP3 ubiquitination degradation (2025 · Journal of Experimental & Clinical Cancer Research · 被引 3)